X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (636) 636
pharmacology & pharmacy (463) 463
single-dose pharmacokinetics (366) 366
pharmacokinetics (345) 345
index medicus (332) 332
male (309) 309
female (275) 275
adult (241) 241
single dose (165) 165
animals (124) 124
middle aged (122) 122
administration, oral (110) 110
adolescent (96) 96
infectious diseases (90) 90
dose-response relationship, drug (88) 88
half-life (86) 86
drug interactions (82) 82
treatment outcome (81) 81
area under curve (78) 78
double-blind (78) 78
aged (77) 77
child (75) 75
pharmacology/toxicology (70) 70
drug therapy (66) 66
children (64) 64
drug administration schedule (64) 64
research (64) 64
toxicology (63) 63
kinetics (62) 62
biological availability (61) 61
anti-bacterial agents - pharmacokinetics (60) 60
bioavailability (60) 60
pharmacodynamics (60) 60
safety (60) 60
pharmacology (59) 59
medicine & public health (58) 58
internal medicine (57) 57
pregnancy (57) 57
analysis (56) 56
microbiology (56) 56
health aspects (55) 55
healthy-volunteers (54) 54
hiv infections - drug therapy (50) 50
infant (50) 50
anti-bacterial agents - therapeutic use (49) 49
immunology (49) 49
anti-bacterial agents - administration & dosage (48) 48
pharmacotherapy (48) 48
single-dose nevirapine (48) 48
dosage and administration (47) 47
chromatography, high pressure liquid (46) 46
pediatrics (46) 46
young adult (46) 46
metabolism (45) 45
in-vitro (44) 44
infant, newborn (44) 44
care and treatment (42) 42
child, preschool (42) 42
drug therapy, combination (42) 42
models, biological (42) 42
therapy (42) 42
human-immunodeficiency-virus (40) 40
biochemistry & molecular biology (39) 39
clinical pharmacokinetics (39) 39
double-blind method (39) 39
drug dosages (39) 39
efficacy (39) 39
multiple dose (39) 39
clinical trials as topic (38) 38
cross-over studies (38) 38
medicine, general & internal (37) 37
tissue distribution (37) 37
antibiotics (36) 36
metabolites (36) 36
time factors (36) 36
clinical trials (35) 35
medicine (35) 35
hiv (34) 34
absorption (33) 33
population pharmacokinetics (33) 33
article (32) 32
drugs (32) 32
metabolic clearance rate (32) 32
review (32) 32
rats (31) 31
infections (30) 30
oncology (29) 29
steady-state pharmacokinetics (29) 29
healthy-subjects (28) 28
injections, intravenous (28) 28
plasma (28) 28
research article (28) 28
single-dose (28) 28
delayed-action preparations (27) 27
prevention (27) 27
studies (27) 27
usage (27) 27
bioequivalence (26) 26
drug resistance (26) 26
anti-bacterial agents - pharmacology (25) 25
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (885) 885
Japanese (7) 7
French (4) 4
Spanish (4) 4
German (3) 3
Korean (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes, Obesity and Metabolism, ISSN 1462-8902, 08/2010, Volume 12, Issue 8, pp. 648 - 658
Type 2 diabetes (T2DM) is a complex disease combining defects in insulin secretion and insulin action. New compounds have been developed for improving... 
DPP-4 inhibitor | Alogliptin | Sitagliptin | Linagliptin | Vildagliptin | Type 2 diabetes mellitus | Pharmacokinetics | Saxagliptin | DIPEPTIDYL PEPTIDASE-4 INHIBITOR | linagliptin | RECEPTOR AGONISTS | saxagliptin | SINGLE-DOSE PHARMACOKINETICS | RENAL IMPAIRMENT | ORAL ANTIDIABETIC AGENTS | sitagliptin | vildagliptin | HEALTHY MALE-VOLUNTEERS | alogliptin | IV INHIBITOR | ENDOCRINOLOGY & METABOLISM | pharmacokinetics | type 2 diabetes mellitus | HEPATIC IMPAIRMENT | TYPE-2 DIABETES-MELLITUS | Dipeptides - pharmacokinetics | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Half-Life | Male | Pyrazines - therapeutic use | Nitriles - pharmacokinetics | Pyrrolidines - therapeutic use | Drug Interactions | Adamantane - therapeutic use | Female | Triazoles - pharmacokinetics | Sitagliptin Phosphate | Adamantane - pharmacokinetics | Adamantane - analogs & derivatives | Triazoles - therapeutic use | Hypoglycemic Agents - therapeutic use | Hypoglycemic Agents - pharmacokinetics | Dipeptides - therapeutic use | Pyrrolidines - pharmacokinetics | Randomized Controlled Trials as Topic | Dipeptidyl-Peptidase IV Inhibitors - pharmacokinetics | Pyrazines - pharmacokinetics | Diabetes Mellitus, Type 2 - drug therapy | Nitriles - therapeutic use | Type 2 diabetes | Physiological aspects | Glucose | Metabolites | Dextrose | Cytochrome P-450
Journal Article
Molecular Pharmaceutics, ISSN 1543-8384, 06/2015, Volume 12, Issue 6, pp. 2026 - 2039
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 11/2016, Volume 72, Issue 11, pp. 1353 - 1361
Journal Article
Journal Article